NCT00847535View on ClinicalTrials.gov

An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 9, 2008

Primary Completion Date

November 2, 2011

Study Completion Date

November 2, 2011

Conditions
Stress Urinary IncontinenceCell Therapy
Interventions
BIOLOGICAL

autologous muscle cell injection

Injection of autologous muscle cells

Trial Locations (3)

37232

Vanderbilt University Medical Center, Nashville

48073

Wm Beaumont Hospital, Royal Oak

M4N 3M5

Sunnybrook Health Sciences Center, Toronto

Sponsors

Lead Sponsor

Cook MyoSite
All Listed Sponsors
lead

Cook MyoSite

INDUSTRY